TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies.
Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, Ciotti M, Das BR, Del Mistro A, Dybikowska A, Giuliano AR, Gudleviciene Z, Gyllensten U, Haws AL, Helland A, Herrington CS, Hildesheim A, Humbey O, Jee SH, Kim JW, Madeleine MM, Menczer J, Ngan HY, Nishikawa A, Niwa Y, Pegoraro R, Pillai MR, Ranzani G, Rezza G, Rosenthal AN, Roychoudhury S, Saranath D, Schmitt VM, Sengupta S, Settheetham-Ishida W, Shirasawa H, Snijders PJ, Stoler MH, Suárez-Rincón AE, Szarka K, Tachezy R, Ueda M, van der Zee AG, von Knebel Doeberitz M, Wu MT, Yamashita T, Zehbe I, Blettner M.
Klug SJ, et al. Among authors: roychoudhury s.
Lancet Oncol. 2009 Aug;10(8):772-84. doi: 10.1016/S1470-2045(09)70187-1. Epub 2009 Jul 20.
Lancet Oncol. 2009.
PMID: 19625214